Pulse Biosciences Clarifies Details of Recent S-3 Filing
Pulse Biosciences, Inc. , a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology for the treatment of atrial fibrillation, today provided...